We are live on ! Find out more
VCYT icon

Veracyte

278 hedge funds and large institutions have $2.31B invested in Veracyte in 2025 Q2 according to their latest regulatory filings, with 36 funds opening new positions, 102 increasing their positions, 103 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.34% more ownership

Funds ownership: 108.68%109.03% (+0.34%)

1% less repeat investments, than reductions

Existing positions increased: 102 | Existing positions reduced: 103

3% less funds holding

Funds holding: 287278 (-9)

8% less capital invested

Capital invested by funds: $2.51B → $2.31B (-$204M)

16% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 43

91% less call options, than puts

Call options by funds: $48K | Put options by funds: $513K

100% less funds holding in top 10

Funds holding in top 10: 30 (-3)

Holders
278
Holders Change
-9
Holders Change %
-3.14%
% of All Funds
3.66%
Holding in Top 10
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
New
36
Increased
102
Reduced
103
Closed
43
Calls
$48K
Puts
$513K
Net Calls
-$465K
Net Calls Change
-$423K
Name Holding Trade Value Shares
Change
Change in
Stake
Nordea Investment Management
51
Nordea Investment Management
Sweden
$7.32M +$91.6K +3,162 +1%
PMAM
52
Picton Mahoney Asset Management
Ontario, Canada
$7.22M +$194K +6,710 +3%
Jennison Associates
53
Jennison Associates
New York
$7.19M -$21.3M -734,486 -73%
NCGI
54
Next Century Growth Investors
Minnesota
$6.56M -$6.76M -233,442 -49%
Bank of New York Mellon
55
Bank of New York Mellon
New York
$6.44M -$286K -9,891 -4%
PHP
56
Parkman Healthcare Partners
Connecticut
$5.96M +$1.57M +54,109 +33%
EAM
57
EFG Asset Management
Oregon
$5.6M +$224K +7,729 +4%
Franklin Resources
58
Franklin Resources
California
$5.57M -$303K -10,452 -5%
Raymond James Financial
59
Raymond James Financial
Florida
$5.55M -$224K -7,746 -4%
Aberdeen Group
60
Aberdeen Group
United Kingdom
$4.92M +$5.27M +181,923 New
VAS
61
Vestmark Advisory Solutions
Massachusetts
$4.79M +$2.35M +81,007 +84%
ECM
62
ExodusPoint Capital Management
New York
$4.76M +$5.1M +175,959 New
CCIA
63
Campbell & Co Investment Adviser
Maryland
$4.69M +$2.82M +97,296 +127%
Balyasny Asset Management
64
Balyasny Asset Management
Illinois
$4.6M +$4.93M +170,248 New
PAM
65
Panagora Asset Management
Massachusetts
$4.52M -$1.19M -41,108 -20%
PIP
66
Palisades Investment Partners
California
$4.39M -$137K -4,734 -3%
MF
67
Magnetar Financial
Illinois
$4.3M +$3.97M +137,219 +625%
D.E. Shaw & Co
68
D.E. Shaw & Co
New York
$4.23M +$4.53M +156,396 New
Lazard Asset Management
69
Lazard Asset Management
New York
$4.13M +$889K +30,686 +25%
Swiss National Bank
70
Swiss National Bank
Switzerland
$4.02M -$37.7K -1,300 -0.9%
QCM
71
QRG Capital Management
Illinois
$3.86M +$95.5K +3,297 +2%
Marshall Wace
72
Marshall Wace
United Kingdom
$3.48M +$3.48M +120,326 +1,444%
RHJA
73
Rice Hall James & Associates
California
$3.47M +$372K +12,835 +11%
Corient Private Wealth
74
Corient Private Wealth
Florida
$3.46M +$1.74K +60 +0%
Man Group
75
Man Group
United Kingdom
$3.42M +$1.23M +42,404 +50%

VCYT Hedge Fund Activity: Q2 2025 in Review

278 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Veracyte (VCYT) for Q2 2025, worth a combined $2.31B — down 8.1% from $2.51B a quarter earlier.

Sellers outnumbered buyers: 43 funds closed out of VCYT and 36 opened new positions — a net loss of 7 holders — while 103 trimmed existing stakes and 102 added.

The largest buyer was Artisan Partners, adding an estimated $31.3M. The largest seller was Driehaus Capital Management, exiting entirely with an estimated $40.1M sold.

  • 278 institutional investors held Veracyte (VCYT) as of Q2 2025, down from 287 in Q1 2025.
  • Funds reported $2.31B of Veracyte stock for Q2 2025, down 8.1% quarter-over-quarter.
  • 36 funds opened new Veracyte positions in Q2 2025 and 43 closed out, a net change of -7 holders.
  • The largest Veracyte buyer in Q2 2025 was Artisan Partners, an estimated $31.3M added.
  • The largest Veracyte seller in Q2 2025 was Driehaus Capital Management, an estimated $40.1M sold.

Based on aggregated 13F filings for Q2 2025.